Allied-Bristol Life Sciences is a new jointly owned enterprise to foster biopharmaceutical research at US universities.

Santaris, which is developing drugs based around locked nucleic acid technology, has been bought for $450m, providing an exit to investors including Novo.

Election software company Scytl has closed a $104m funding round, securing $44m from the second tranche after SAP invested $20m earlier this year.

Thee months after making its first venture investment, Bauer is following the lead of competitor Axel Springer by launching a dedicated fund that will focus on software.

Researchers at the Technical University of Denmark crush all previous records with internet transfer speeds 430 times faster than current commercial technology.

Research at Sheffield University has taken a significant step towards commercialising perovskite solar cells.

Durham spin-out FScan is exclusively licensing a prostate cancer diagnostic technology to Glide Pharmaceuticals Technology.